Legal Representation
Attorney
Tracy-Gene G. Durkin
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 10, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 10, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 26, 2022 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Sep 21, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 20, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 20, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 7, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 7, 2022 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 11, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 9, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 9, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Mar 9, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 14, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 10, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 10, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 10, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 10, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 12, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 10, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 10, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 10, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 10, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 14, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 14, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 25, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 11, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 7, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 6, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 6, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 6, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 6, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 6, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 30, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 29, 2019 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| May 29, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 30, 2018 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Nov 30, 2018 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 30, 2018 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 29, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 28, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 28, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 28, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 29, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 29, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 29, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 29, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 22, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment and prevention of cancer
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the stylized letters "A", "D", "C", and "T".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
042
044